Handelsbanken Fonder’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.72M | Buy |
46,675
+2,900
| +7% | +$107K | 0.01% | 719 |
|
2025
Q1 | $1.55M | Sell |
43,775
-600
| -1% | -$21.2K | 0.01% | 750 |
|
2024
Q4 | $1.94M | Sell |
44,375
-2,400
| -5% | -$105K | 0.01% | 687 |
|
2024
Q3 | $2.12M | Buy |
46,775
+10,100
| +28% | +$458K | 0.01% | 647 |
|
2024
Q2 | $1.42M | Sell |
36,675
-3,500
| -9% | -$136K | 0.01% | 694 |
|
2024
Q1 | $1.3M | Hold |
40,175
| – | – | 0.01% | 743 |
|
2023
Q4 | $1.15M | Buy |
40,175
+25,975
| +183% | +$745K | 0.01% | 747 |
|
2023
Q3 | $393K | Buy |
14,200
+800
| +6% | +$22.1K | ﹤0.01% | 1177 |
|
2023
Q2 | $358K | Buy |
13,400
+1,900
| +17% | +$50.8K | ﹤0.01% | 1252 |
|
2023
Q1 | $249K | Hold |
11,500
| – | – | ﹤0.01% | 1371 |
|
2022
Q4 | $274K | Hold |
11,500
| – | – | ﹤0.01% | 1298 |
|
2022
Q3 | $227K | Hold |
11,500
| – | – | ﹤0.01% | 1393 |
|
2022
Q2 | $224K | Hold |
11,500
| – | – | ﹤0.01% | 1463 |
|
2022
Q1 | $293K | Sell |
11,500
-5,300
| -32% | -$135K | ﹤0.01% | 1529 |
|
2021
Q4 | $423K | Buy |
16,800
+4,700
| +39% | +$118K | ﹤0.01% | 1462 |
|
2021
Q3 | $333K | Hold |
12,100
| – | – | ﹤0.01% | 1563 |
|
2021
Q2 | $384K | Buy |
12,100
+4,100
| +51% | +$130K | ﹤0.01% | 1548 |
|
2021
Q1 | $367K | Hold |
8,000
| – | – | ﹤0.01% | 1357 |
|
2020
Q4 | $317K | Buy |
+8,000
| New | +$317K | ﹤0.01% | 1379 |
|